These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 32831296)

  • 1. CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia.
    Biernacki MA; Foster KA; Woodward KB; Coon ME; Cummings C; Cunningham TM; Dossa RG; Brault M; Stokke J; Olsen TM; Gardner K; Estey E; Meshinchi S; Rongvaux A; Bleakley M
    J Clin Invest; 2020 Oct; 130(10):5127-5141. PubMed ID: 32831296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gata2 deficiency delays leukemogenesis while contributing to aggressive leukemia phenotype in Cbfb-MYH11 knockin mice.
    Saida S; Zhen T; Kim E; Yu K; Lopez G; McReynolds LJ; Liu PP
    Leukemia; 2020 Mar; 34(3):759-770. PubMed ID: 31624376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of additional chromosomal abnormalities in adult acute myeloid leukemia with inv (16)/t(16;16)/CBFB::MYH11.
    Gao J; Santana-Santos L; Fu L; Alvey E; Chen Q; Wolniak K; Xia Z; Aqil B; Behdad A; Ji P; Sukhanova M; Abaza Y; Altman JK; Chen YH; Lu X
    Eur J Haematol; 2024 Jun; 112(6):964-974. PubMed ID: 38388794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology.
    Albano F; Anelli L; Zagaria A; Coccaro N; Tota G; Impera L; Minervini CF; Cellamare A; Delia M; Minervini A; Casieri P; Specchia G
    Hum Pathol; 2014 Mar; 45(3):643-7. PubMed ID: 24342433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Establishment of a new method for screening of CBFB-MYH11 fusion gene in acute myeloid leukemia and its value in clinical use].
    Chen C; Li ZP; Lu QY; Liu ZM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1077-81. PubMed ID: 23114122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patients.
    Schnittger S; Bacher U; Haferlach C; Kern W; Haferlach T
    Leukemia; 2007 Apr; 21(4):725-31. PubMed ID: 17287858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteogenomic analysis reveals cytoplasmic sequestration of RUNX1 by the acute myeloid leukemia-initiating CBFB::MYH11 oncofusion protein.
    Day RB; Hickman JA; Xu Z; Katerndahl CD; Ferraro F; Ramakrishnan SM; Erdmann-Gilmore P; Sprung RW; Mi Y; Townsend RR; Miller CA; Ley TJ
    J Clin Invest; 2023 Dec; 134(4):. PubMed ID: 38061017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of a novel CBFB/MYH11 variant fusion transcript (K-type) showing partial insertion of exon 6 of CBFB gene using two commercially available multiplex RT-PCR kits.
    Park TS; Lee ST; Song J; Lee KA; Lee JH; Kim J; Lee HJ; Han JH; Kim JK; Cho SR; Choi JR
    Cancer Genet Cytogenet; 2009 Mar; 189(2):87-92. PubMed ID: 19215788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The loss or absence of minimal residual disease of <0·1% at any time after two cycles of consolidation chemotherapy in CBFB-MYH11-positive acute myeloid leukaemia indicates poor prognosis.
    Duan W; Liu X; Jia J; Wang J; Gong L; Jiang Q; Zhao T; Wang Y; Zhang X; Xu L; Zhao X; Qin Y; Shi H; Chang Y; Huang X; Jiang H
    Br J Haematol; 2021 Jan; 192(2):265-271. PubMed ID: 32588434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CBFB-MYH11 hinders early T-cell development and induces massive cell death in the thymus.
    Zhao L; Cannons JL; Anderson S; Kirby M; Xu L; Castilla LH; Schwartzberg PL; Bosselut R; Liu PP
    Blood; 2007 Apr; 109(8):3432-40. PubMed ID: 17185462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute myeloid leukemia with type I CBFB::MYH11 fusion gene not detected by screening test for leukemia-related chimeric genes].
    Utsumi S; Shima T; Kubara C; Semba Y; Hayashi M; Takigawa K; Yoshino T; Minami M; Matsuo Y; Kuriyama T; Akashi K; Maeda T; Taniguchi S; Eto T
    Rinsho Ketsueki; 2023; 64(12):1503-1507. PubMed ID: 38220149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptic insertion of CBFB into MYH11 leading to a type D fusion in acute myeloid leukemia with normal karyotype.
    Yamamoto K; Kurata K; Kitao A; Sakai R; Matsumoto S; Matsumoto H; Saegusa J; Yakushijin K; Minami H
    Int J Lab Hematol; 2022 Feb; 44(1):e36-e39. PubMed ID: 34490987
    [No Abstract]   [Full Text] [Related]  

  • 13. Jumping translocation involving chromosome 13q in a patient with Crohn's Disease and inv(16)(p13.1q22)/CBFB-MYH11 acute myeloid leukemia.
    Clarke S; de Kraa R; Chuah H; Creeper K; Leahy MF; Wright M
    Cancer Genet; 2022 Aug; 266-267():7-14. PubMed ID: 35613501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Cbfb in hematopoiesis and perturbations resulting from expression of the leukemogenic fusion gene Cbfb-MYH11.
    Kundu M; Chen A; Anderson S; Kirby M; Xu L; Castilla LH; Bodine D; Liu PP
    Blood; 2002 Oct; 100(7):2449-56. PubMed ID: 12239155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myeloid leukemia with cryptic CBFB-MYH11 type D.
    Kobayashi T; Ichikawa M; Kamikubo Y; Kurokawa M
    Int J Clin Exp Pathol; 2013; 6(1):110-2. PubMed ID: 23236551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of a novel CBFB-MYH11 fusion transcript in acute myeloid leukemia M1 with inv(16)(p13q22).
    Kurata K; Yamamoto K; Okazaki Y; Noguchi Y; Matsui K; Matsumoto H; Inui Y; Yakushijin K; Ito M; Nakamachi Y; Matsuoka H; Saegusa J; Minami H
    Cancer Genet; 2020 Feb; 241():72-76. PubMed ID: 31353165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Basis and Targeted Inhibition of CBFβ-SMMHC Acute Myeloid Leukemia.
    Castilla LH; Bushweller JH
    Adv Exp Med Biol; 2017; 962():229-244. PubMed ID: 28299661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exome sequencing identifies recurring FLT3 N676K mutations in core-binding factor leukemia.
    Opatz S; Polzer H; Herold T; Konstandin NP; Ksienzyk B; Zellmeier E; Vosberg S; Graf A; Krebs S; Blum H; Hopfner KP; Kakadia PM; Schneider S; Dufour A; Braess J; Sauerland MC; Berdel WE; Büchner T; Woermann BJ; Hiddemann W; Spiekermann K; Bohlander SK; Greif PA
    Blood; 2013 Sep; 122(10):1761-9. PubMed ID: 23878140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic values of D816V KIT mutation and peri-transplant CBFB-MYH11 MRD monitoring on acute myeloid leukemia with CBFB-MYH11.
    Cho BS; Min GJ; Park SS; Park S; Jeon YW; Shin SH; Yahng SA; Yoon JH; Lee SE; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Kim M; Kim Y; Kim HJ
    Bone Marrow Transplant; 2021 Nov; 56(11):2682-2689. PubMed ID: 34183780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cbfb/Runx1 repression-independent blockage of differentiation and accumulation of Csf2rb-expressing cells by Cbfb-MYH11.
    Hyde RK; Kamikubo Y; Anderson S; Kirby M; Alemu L; Zhao L; Liu PP
    Blood; 2010 Feb; 115(7):1433-43. PubMed ID: 20007544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.